Black Cohosh Tea for Menopause Symptoms
Black cohosh is not recommended for treating menopausal symptoms based on the most recent high-quality evidence showing no significant benefit over placebo, and there are documented safety concerns including reports of liver failure. 1, 2
Evidence Against Efficacy
The highest quality evidence comes from a 2012 Cochrane systematic review of 16 randomized controlled trials involving 2,027 women, which found:
- No significant difference between black cohosh and placebo for hot flush frequency (mean difference 0.07 flushes per day; 95% CI -0.43 to 0.56; P=0.79) 2
- No significant difference in overall menopausal symptom scores (SMD -0.10; 95% CI -0.32 to 0.11; P=0.34) 2
- Black cohosh was significantly less effective than hormone therapy for both hot flush frequency and menopausal symptom scores 2
A 2023 meta-analysis showed some benefit, but this contradicts the more rigorous Cochrane review and included lower quality studies 3. The 2008 systematic review similarly concluded that evidence does not consistently demonstrate an effect of black cohosh on menopausal symptoms 4.
Safety Concerns
Multiple reports of liver failure have been documented with black cohosh use, making it potentially dangerous even if it were effective 1. Additional adverse effects reported in clinical trials include nausea, vomiting, headaches, dizziness, breast pain, and weight gain 5.
Guideline Recommendations
Major clinical guidelines specifically recommend against black cohosh:
- A 2008 randomized trial in healthy menopausal women demonstrated that black cohosh provided no benefit, while only estrogen was effective 1
- The Annals of Oncology guidelines note that "the safety of these treatments following breast cancer is not established" and highlight the liver failure reports 1
- Guidelines emphasize that evidence on complementary and alternative treatments, including black cohosh, does not support their efficacy 1
Recommended Alternatives
For women seeking relief from menopausal symptoms, evidence-based first-line options include:
Nonhormonal Pharmacologic Options
- Gabapentin 900 mg/day reduces hot flash severity by 46% vs 15% with placebo, with no drug interactions 6
- Venlafaxine 37.5-75 mg daily reduces hot flash scores by 37-61% 6
- Paroxetine 7.5 mg daily reduces frequency and severity by 62-65% (avoid with tamoxifen due to drug interaction) 6
Nonpharmacologic Approaches
- Acupuncture has shown equivalence or superiority to venlafaxine or gabapentin in some studies 6
- Weight loss ≥10% of body weight may eliminate hot flash symptoms 6
- Cognitive behavioral therapy reduces perceived burden of hot flashes 6
- Paced respiration training for 20 minutes daily shows significant benefit 6
Hormonal Therapy (When Appropriate)
- Menopausal hormone therapy remains the most effective treatment, reducing hot flashes by approximately 75% compared to placebo, but should only be used when nonhormonal options fail and after careful risk-benefit discussion 6
- Use the lowest effective dose for the shortest duration possible 1
- Contraindicated in women with history of breast cancer, venous thromboembolism, stroke, or active liver disease 6
Clinical Approach
Start with gabapentin 900 mg at bedtime if the patient has concurrent sleep disturbance or is on multiple medications (no drug interactions), as it has equivalent efficacy to estrogen for hot flashes 6. If gabapentin is ineffective or not tolerated after 4-6 weeks, switch to venlafaxine 37.5-75 mg daily 6. Review efficacy at 2-4 weeks for SSRIs/SNRIs and 4-6 weeks for gabapentin 6.
Avoid black cohosh entirely given the lack of proven efficacy, documented liver toxicity risk, and availability of superior evidence-based alternatives 1, 2.